NCC Limited informed the exchanges on Tuesday that it has bagged a new order worth Rs. 848 crore in the month of September 2019. The order pertains to Building Division and is received from a State Government agency and does not include any internal orders.

Following stocks are close to their 52-weeks low as at 12:31 p.m. on October 01, 2019.

The markets on October 01, 2019 opened gap up. BSE Sensex is trading at 38,706.19, up by 38.36 points and the Nifty is trading at 11,482.95, up by 8.50 points.

Cadila Healthcare on Monday has informed the bourses that it has entered into an agreement with Medicure lnc, a cardiovascular pharmaceutical company to sell its right, title and interest in Zypitamagt (Pitavastatin)

As on Q1FY20, the company’s order inflow was at Rs. 1130 crore and total order book was at Rs. 10,173 crore. This translates to book-to-bill of 3.1x giving strong revenue visibility for the next 2-3 years

On Tuesday, Natco Pharma Limited informed the bourses about the successful closure of inspection at its Andhra facility, with the receipt of an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA).

The plant will remain shut down for an approximate period of 90 days. This plant is major revenue driver for the company. During fiscal year 2018-19, it contributed nearly Rs. 420.61 crore to the revenue, representing 95 per cent of total revenue.

The public sector lender, Bank of Baroda has announced capital infusion of Rs. 7000 crore by the Government of India.

Overall volumes in futures & options currently stand at 1,48,92,810 contracts with a turnover of Rs. 9,93,216.12 crore.

Overall volumes in futures & options currently stand at 1,48,92,810 contracts with a turnover of Rs. 9,93,216.12 crore.